
OPEN LETTER:
ANIL PARWANI Professor of Pathology and Biomedical Informatics, Chair of Pathology Department, The Ohio State University
Dear Colleagues,
It is my great pleasure to offer my full support for the 12th Digital Pathology & AI Congress, co-located with the 3rd American Spatial Biology Congress, taking place on May 7–8, 2026 in Columbus, Ohio.
We are at a defining moment in the evolution of pathology. Digital pathology and artificial intelligence are no longer future concepts—they are actively reshaping how we diagnose disease, generate knowledge from tissues, and deliver precision medicine to patients. When combined with advances in spatial biology, these technologies provide unprecedented insight into tissue architecture, cellular interactions, and disease biology across scales.
At The Ohio State University, we have witnessed firsthand how digital pathology and AI can transform clinical workflows, enable computational discovery, and bridge research and patient care. From whole-slide imaging and AI-assisted diagnostics to spatial multi-omics and translational research, these tools are redefining what is possible in modern pathology. Importantly, their successful adoption depends not only on technological innovation, but also on collaboration, shared learning, and open dialogue across academia, healthcare, and industry.
This Congress brings together exactly that community. By uniting pathologists, scientists, clinicians, computational experts, and technology innovators, the meeting provides a vital forum to explore real-world implementation, regulatory considerations, and emerging scientific applications. The co-location of digital pathology and spatial biology is particularly timely, reflecting how closely these disciplines are converging to drive the next generation of precision diagnostics and therapeutics.
I am especially pleased that this meeting is being held in Columbus and in collaboration with The Ohio State University. It offers a unique opportunity to engage with leaders while showcasing how integrated digital and spatial approaches are being applied in both research and clinical settings.
I look forward to participating in the Congress and to delivering the keynote address, “Journey to Precision Pathology: The Role of Digital Pathology and AI.” I strongly encourage colleagues across pathology, biomedical research, and industry to join us for what promises to be an impactful and forward-looking event.
I hope to see you in Columbus in May 2026.
Anil Parwani


